Ethyl 5-methylpyrazine-2-carboxylate

Catalog No.: 
ACWLUD914
CAS No.: 
41110-34-3
Molecular Formula: 
C8H10N2O2
Molecular Weight: 
166.18
Ethyl 5-methylpyrazine-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$73.00In stockInquiry
100g97%$283.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 5-methylpyrazine-2-carboxylate
IUPAC Nameethyl 5-methylpyrazine-2-carboxylate
MDL No.MFCD05662506
Molecular FormulaC8H10N2O2
Molecular Weight166.18
SMILESO=C(C1=NC=C(C)N=C1)OCC
InChI KeyDKEZXLQHHZBQAV-UHFFFAOYSA-N
SynonymETHYL 5-METHYLPYRAZINE-2-CARBOXYLATE | 41110-34-3 | MFCD05662506 | ethyl5-methylpyrazine-2-carboxylate | SCHEMBL1644521 | DTXSID60583021 | DKEZXLQHHZBQAV-UHFFFAOYSA-N | AMY15961 | Ethyl 5-methyl-2-pyrazinecarboxylate | AKOS008947955 | DS-16891 | 5-methylpyrazinecarboxylic acid
CAS No.41110-34-3
PubChem CID16114819

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACWLUD914 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQFSM068 route compound structure diagram
    ACQFSM0682091363-93-6In Stock
  2. Then
  3. ACWLUD914 route product structure diagram
    ACWLUD91441110-34-3In Stock
Inquiry

2. ACWLUD914 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWLUD914 route product structure diagram
    ACWLUD91441110-34-3In Stock
Inquiry

3. ACWLUD914 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWLUD914 route product structure diagram
    ACWLUD91441110-34-3In Stock
Inquiry

Comments (0)